Antibiotic prophylaxis in children with ureteric stents: Bliss or misery?
| Autor: | Abdullah Khalid Mohammedkhalil, Mohammed A. Almarghoub, Abdullah A Mesawa, Basim Alsaywid, Wesam Abuznadah, Zhour Barnawi |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
medicine.drug_class Urology Urinary system medicine.medical_treatment Antibiotics 030232 urology & nephrology bacteriuria Bacteriuria lcsh:RC870-923 urologic and male genital diseases urogenital disease 03 medical and health sciences 0302 clinical medicine Internal medicine medicine Antibiotic prophylaxis Ureteric stent business.industry Incidence (epidemiology) Retrospective cohort study Perioperative lcsh:Diseases of the genitourinary system. Urology medicine.disease female genital diseases and pregnancy complications 030220 oncology & carcinogenesis ureteric stent and pediatric Original Article urinary tract infection business |
| Zdroj: | Urology Annals, Vol 11, Iss 4, Pp 421-425 (2019) Urology Annals |
| ISSN: | 0974-7796 |
| Popis: | Introduction: The risk of urinary tract infection (UTI) in patients with a ureteric stent is influenced by several factors such as duration of stenting. Antibiotic prophylaxis has been previously used for the prevention of UTI in patients with common urological pathologies. The aims of this study were to evaluate the incidence, to identify the risk factors of symptomatic UTI in pediatric patients with ureteric stents, and to review the effectiveness of antibiotic prophylaxis in reducing the rate of symptomatic UTI compared to a no intervention (control) group. Materials and Methods: This was a retrospective cohort study that was held at a tertiary hospital in Jeddah, Saudi Arabia. The study included 110 pediatric patients who were younger than 18 years and who required ureteric stent insertion. Disregarding gender difference, the patients were divided into two main groups: an antibiotic group and a control group. The patients in the antibiotic group (Group 1) received continuous antibiotic prophylaxis from the date of ureteral stent insertion until removal, while the patients in the control group (Group 2) received antibiotics during the perioperative period only. Results: A total of 110 patients were included in the final analysis. Group 1 patients who were given antibiotic prophylaxis during the presence of ureteric stent were 54 patients (49%). Group 2 patients who were only given antibiotic during the perioperative period were 56 (51%). Males compromised 73% (n = 80) of the sample population, while females were 27% (n = 30). The prevalence of symptomatic UTI was significantly reduced from 25% in the control group to 7% in the antibiotic group (P < 0.004). Conclusion: Antibiotic prophylaxis has significantly reduced the risk of symptomatic UTI by 68% in comparison to the control group. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
| Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |